Pulmonary Nodule Cohort

Lung Cancer Clinical Trial

— liquidNodule  

Official title:

Pulmonary Nodule Cohort

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04049422
• Other study ID #: 1907-099-1048
• Status: Not yet recruiting
• Start date: August 6, 2019
• Est. completion date: July 31, 2029

Study information

• Verified date: August 2019
• Source: Seoul National University Hospital
• Contact: Young Sik Park, MD
• Phone: +82-2-2072-7214
• Email: mdyspark[@]gmail.com
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The aim of this study is to identify the clinical features of pulmonary nodules and establish a cohort to identify biomarkers for lung cancer.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 1000
• Est. completion date: July 31, 2029
• Est. primary completion date: July 31, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• age >= 18

• pulmonary nodule(s) on chest CT, which satisfy at least one of the following two criteria,

• 4A or above in Lung-RADS v1.1

• lung cancer risk >= 5% in Brock model

Exclusion Criteria:

• already proven lung cancer

Related Conditions & MeSH terms

• Lung Cancer
• Multiple Pulmonary Nodules
• Pulmonary Nodule, Solitary
• Solitary Pulmonary Nodule

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Seoul National University Hospital

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Incidence of lung cancer	incidence of pathologically proven lung cancer	up to 5 years